Specifically, SIRT1‐FOXO1 was discovered to ameliorate depression‐related phenotypes in Parkinson's disease (PD) mouse models by regulating the transcription of monoamine oxidase A (MAO‐A) [37]. Here, FOXO1 is linked to depressive symptom measurement.